Weighing in on heart failure: the potential impact of bariatric surgery

Tanuka Datta1, Andrew J Lee2, Rachel Cain2

  • 1Department of Internal Medicine, Division of Cardiology, Thomas Jefferson University, Philadelphia, PA, USA. tanuka.datta@jefferson.edu.

Heart Failure Reviews
|January 26, 2021
PubMed

Insights

Obesity significantly increases heart failure risk. Bariatric surgery may offer a viable treatment strategy for individuals with obesity and heart failure, improving cardiovascular outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Surgical Interventions

Background:

  • Obesity is a global epidemic with substantial economic and health implications.
  • Obesity is a significant risk factor for developing heart failure, impacting cardiovascular physiology.
  • Heart failure presents a major health challenge, exacerbated by comorbid conditions like obesity.

Purpose of the Study:

  • To review the individual impacts of heart failure and obesity.
  • To explore the physiological mechanisms linking obesity and heart failure.
  • To introduce bariatric surgery as a weight loss treatment strategy for this population.

Main Methods:

  • Literature review focusing on obesity and heart failure.
  • Analysis of physiological mechanisms connecting obesity and heart failure.
  • Review and comparison of existing studies on bariatric surgery outcomes in patients with obesity and heart failure.

Main Results:

  • Obesity dramatically elevates the risk of heart failure.
  • Bariatric surgery is presented as a potential therapeutic approach.
  • Existing literature on bariatric surgery outcomes in this cohort is synthesized and contrasted.

Conclusions:

  • Understanding the interplay between obesity and heart failure is crucial.
  • Bariatric surgery warrants consideration as a treatment for obesity in heart failure patients.
  • Further research is needed to fully elucidate the long-term effects of bariatric surgery on heart failure.

Related Concept Videos

Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
561
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
247
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.2K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
262
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
126
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
224